metricas
covid
Buscar en
Enfermería Clínica
Toda la web
Inicio Enfermería Clínica Factores de influencia en la duración de la lactancia materna en el Hospital de...
Journal Information
Vol. 13. Issue 6.
Pages 329-336 (January 2003)
Share
Share
Download PDF
More article options
Vol. 13. Issue 6.
Pages 329-336 (January 2003)
Factores de influencia en la duración de la lactancia materna en el Hospital de Sant Pau de Barcelona
Factors influencing duration ofbreast feeding in the Hospital de Sant Pau in Barcelona (Spain)
Visits
146
Antoni Oliver
Corresponding author
net@teleline.es

Correspondencia: Benito Pérez Galdós, 13, 4.° A. 03690. Sant Vicenç del Raspeig. Alicante. España
, Núria Torras, Lourdes Martínez
Matronas. Servicio de Ginecología y Obstetricia. Hospital de la Santa Creu i Sant Pau. Barcelona. España
This item has received
Article information
Resumen
Objetivo

Valorar los aspectos relacionados con el inicio y duración de la lactancia materna (LM) en mujeres atendidas en un hospital de Barcelona

Material y método

Estudio descriptivo longitudinal. Muestra aleatoria de 309 mujeres. Datos recogidos el día del parto y mediante encuesta telefónica a los 6 meses sobre rutinas hospitalarias, duración de la LM y filiación de las madres

Resultados

Se obtuvo un 91% de respuesta. La mediana de duración de la LM exclusiva fue de 3 meses y de la LM mixta de un mes; la mayor densidad de abandono se encontró al segundo mes. Los factores que se relacionan con una mayor duración de LM son la LM a demanda y no ofrecer suplementos y chupetes u otros líquidos diferentes de la leche materna

Conclusiones

Existe una mejora del apoyo hospitalario a las prácticas que fomentan la LM, pero deben desaconsejarse las pautas rígidas, la administración de líquidos diferentes de la leche materna y los chupetes. Es necesario aumentar los recursos dedicados a la LM después del alta

Palabras clave:
Lactancia materna
Duración de la lactancia
Prevalencia
Cuestionario telefónico
Objective

To evaluate factors related to the initiation and duration of breastfeeding in women attending a hospital in Barcelona (Spain)

Material and method

A descriptive, longitudinal study with random sampling of 309 women was performed. Data were collected on the day of delivery and through a telephone survey six months later on routine hospital practices, duration of breastfeeding and maternal practices

Results

The response rate was 91%. The median duration of exclusive breastfeeding was three months and that of mixed breastfeeding was one month. Breastfeeding was discontinued mainly in the second month. Factors related with greater duration of breastfeeding were feeding on demand and not supplying supplements, pacifiers or liquids other than breast milk

Conclusions

Hospital practices that support breastfeeding have improved. However, mothers should be advised against following rigid feeding practices, providing liquids other than breast milk, and using pacifiers. Resources aimed at post-discharge breastfeeding should be increased

Keywords:
Breast feeding
Duration of breastfeeding
Prevalence
Telephone survey

Article

These are the options to access the full texts of the publication Enfermería Clínica
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Enfermería Clínica

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos